Roche-Backed Freenome Continues Industry’s Private Funding Rally with $254M Raise
Amount Raised
$254 Million
Round Type
Series A
Investors
Description
Freenome announced a $254 million private financing round, led by Roche, to support the development of its multiomics-based early detection tests for cancer.
Quick answer
Freenome raised $254 Million in a Series A round, dated February 15, 2024. Investors: American Cancer Society’s Bright Edge Ventures, Ark Investments, Cormorant Capital, Bain Capital Life Sciences and Roche. Freenome is based in Brisbane, California, United States.
- How much did Freenome raise?
- Freenome raised $254 Million in a Series A round on February 15, 2024.
- Who invested in Freenome?
- American Cancer Society’s Bright Edge Ventures, Ark Investments, Cormorant Capital, Bain Capital Life Sciences and Roche are named as investors in this round.
- What does Freenome do?
- Freenome is a biotechnology company with a comprehensive multiomics platform for early cancer detection using a routine blood draw.
- Where is Freenome based and how big is it?
- Freenome is based in Brisbane, California, United States. Fundz records about 396 employees.
- Who are the decision-makers at Freenome?
- Fundz holds 1 contact at Freenome. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Venture Capital around the same time
Companies in the same sectors as Freenome that raised within 45 days of this round, from Fundz verified event records.
- Enliven Therapeutics raised $90M on March 21, 2024.
- Enliven Therapeutics raised $90M (Post-IPO Equity) on March 20, 2024.
- Aprea Therapeutics raised $34M (Funding Round) on March 18, 2024.
- Zephyr AI, Inc. raised $111M (Series A) on March 13, 2024.
- Aprea Therapeutics raised $34M (Post-IPO Equity) on March 12, 2024.
- MAIA Biotechnology raised $2.9M (Seed) on March 11, 2024.
Who to call at Freenome, and when
A new round usually means Freenome is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Freenome raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Freenome, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Freenome. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Freenome raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansFreenome raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.